Why the study?
Balloon-tipped temporary pacemakers carry risks of dislodgement and thromboembolism, but evidence comparing clinical outcomes between temporary-permanent pacemakers and balloon-tipped temporary pacemakers remains scarce.
Do Temporary Permanent Pacemakers (TPPM) improve safety and clinical outcomes compared to Balloon Tipped Temporary Pacemakers (BTTP) in patients requiring temporary pacing?
Do Temporary Permanent Pacemakers (TPPM) improve safety and clinical outcomes compared to Balloon Tipped Temporary Pacemakers (BTTP) in patients requiring temporary pacing?
Temporary-permanent pacemakers offer a superior safety profile and enable patient ambulation compared to traditional balloon-tipped temporary pacemakers.
TPPM was associated with fewer complications than BTTP; leaves open need for RCTs before practice change.
BACKGROUND: Balloon Tipped Temporary Pacemakers (BTTP) are the most used temporary pacemakers; however, they are associated with a risk of dislodgement and thromboembolism. Recently, Temporary Permanent Pacemakers (TPPM) have been increasingly used. Evidence of outcomes with TPPM compared to BTTP remains scarce. METHODS: Retrospective, chart review study evaluating all patients who underwent temporary pacemaker placement between 2014 and 2022 (N = 126) in the cardiac catheterization laboratory (CCL) at a level 1 trauma center. Primary outcome of this study is to evaluate the safety profile of TPPM versus BTTP. Secondary objectives include patient ambulation and healthcare utilization in patients with temporary pacemakers. RESULTS: Both groups had similar baseline characteristics distribution including gender, race, and age at temporary pacemaker insertion (p > .05). Subclavian vein was the most common site of access for the TPPM cohort (89.0%) versus the femoral vein in the BTTP group (65.1%). Ambulation was only possible in the TPPM group (55.6%, p < .001). Lead dislodgement, venous thromboembolism, local hematoma, and access site infections were less frequently encountered in the TPPM group (OR = 0.23 [95% CI (0.10-0.67), p < .001]). Within the subgroup of patients with TPPM, 36.6% of the patients were monitored outside the ICU setting. There was no significant difference in the pacemaker-related adverse events among patients with TPPM based on their in-hospital setting. CONCLUSION: TPPM is associated with a more favorable safety profile compared to BTTP. They are also associated with earlier patient ambulation and reduced healthcare utilization.
No takes yet. Share an insight, caveat, or question.
Chedid et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: